Sexually Transmitted Disease Testing Market revenue to exceed USD 145 Billion by 2033, says Research Nester
31. Juli 2023 07:00 ET
|
Research Nester
New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global sexually transmitted disease testing market size is predicted to grow at a CAGR of over ~6% from 2023 to 2035. The market is projected to...
Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine
12. April 2023 08:30 ET
|
Blue Water Vaccines Inc.
CINCINNATI, April 12, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address...
Blue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business Development
06. Februar 2023 10:15 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced the appointment of Frank Jaeger, seasoned commercial...
Blue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San Antonio
21. November 2022 08:00 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address...
Global Sexually Transmitted Diseases (STD) Treatment Market is Expected to Reach USD 84.81 Billion By 2026 : Fior Markets
15. Juli 2019 12:46 ET
|
Fior Markets
New Jersey, NJ, July 15, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled, "Sexually Transmitted Diseases (STD) Treatment Market by Disease Type (Chlamydia, Syphilis, Herpes Simplex...
Earth Science Tech, Inc. (ETST) Orders First Commercial Production Run of Hygee™ Kits
18. Dezember 2018 08:00 ET
|
Earth Science Tech, Inc.
Launch of new medical device to fight STIs slated for early 2019 DORAL, Florida, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative...
Earth Science Tech, Inc. Announces New Agreement with a Private Laboratory to Develop and Commercialize MSN-2 Medical Device
09. Januar 2018 08:00 ET
|
Earth Science Tech, Inc.
Doral, FL,, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or, the “Company"), an innovative biotech company that operates in the fields of hemp cannabinoid...
Cempra to Present Solithromycin IV Data at ATS 2016
12. Mai 2016 16:05 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., May 12, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Participate in Nature's Webcast on Combating Antibiotic Resistance on March 9
08. März 2016 16:10 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., March 08, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at the Cowen and Company 36th Annual Healthcare Conference
29. Februar 2016 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...